Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 2177-2180

  Hotta, Katsuyuki ^a,b   Segawa, Yoshihiko ^a   Takigawa, Nagio ^a   Kishino, Daizo ^a   Saeki, Hideyuki ^a   Nakata, Masao ^a   Mandai, Koichi ^a   Eguchi, Kenji ^a  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Carcinoembryonic antigen; Non small cell lung cancer; Surgical resection

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; NEOPLASM STAGING; PNEUMONECTOMY; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033877729     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Backer CL, Shields TW, Lockhart CG, Vogelzang R, LoCicero JD: Selective preoperative evaluation for possible N2 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 93: 337-343, 1987.
2. Concannon JP, Dalbow MH, Hodgson SE, Headings JJ, Markopoulos E, Mitchell J et al: Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma. Cancer 42: 1477-1483, 1978.
3. Dent PB, Mcculloch PB, Wesley-James O, Maclaren R, Muirhead W, Dunnett CW: Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma. Cancer 42: 1484-1491, 1978.
4. Dillemans B, Deneffe G, Verschakelen J and Decramer M: Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer: a study of 569 patients. Eur J Cardiothorac Surg 8: 37-42, 1994.
5. Ginsberg RJ: Evaluation of the mediastinum by invasive techniques. Surg Clin North Am 67: 1025-1035, 1987.
6. Maeda Y, Segawa Y, Takigawa N, Takata I, Fujimoto N: Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer. Internal Medicine 35: 764-771, 1996.
7. Mountain CF: Revisions in the international system for staging lung cancer. Chest 111: 1710-1717, 1997.
8. Nagasaki F, Flehinger BP, Martini N: Complications of surgery in the treatment of carcinoma of the lung. Chest 82: 25-29, 1982.
9. National Institutes of Health Consensus Development Conference Statement: Carcinoembryonic antigen: its role as a marker in the management of cancer. Cancer Res 41: 2017-2018, 1981.
10. Rubins JB, Dunitz J, Rubins HB, Maaddaus MA, Niewoehner DE: Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 116: 412-416, 1998.
11. Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y et al: Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy. Cancer 57: 1318-1323, 1986.
12. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y: Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 117: 593-598, 1999.
13. The World Health Organization: Histological Typing of Lung Tumours. Second edition. Am J Clin Pathol 77: 123-136, 1982.
14. Van Schil PE, Van Hee RH, Schoofs EL: The value of mediastinoscopy in preoperative staging of patients with primary lung cancer. J Thorac Cardiovasc Surg 97: 240-244, 1989.
15. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A et al: Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16: 2142-2149, 1998.
16. Vincent RG, Chu TM, Fergen TB, Ostrander M: Carcinoembryonic antigen in 228 patients with caricinoma of the lung. Cancer 36: 2069-2076, 1975.